Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population

Drug and Alcohol Dependence

Volumn 152, Issue , 2015, Pages 246-256

  Hasin, Deborah S ^a,b,c   Shmulewitz, Dvora ^a,c   Stohl, Malka ^c   Greenstein, Eliana ^c   Aivadyan, Christina ^c   Morita, Kara ^c   Saha, Tulshi ^d   Aharonovich, Efrat ^a,c   Jung, Jeesun ^d   Zhang, Haitao ^d   Nunes, Edward V ^a,c   Grant, Bridget F ^d  

^a Columbia University ^*  (United States)

^b New York State Psychiatric Institute ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Alcohol use disorder; Alcohol Use Disorder and Associated Disabilities Interview Schedule 5; Psychiatric Research Interview for Substance and Mental Disorders 5; Reliability; Substance use disorder; Validity

Indexed keywords

ADULT; AGED; ALCOHOL USE DISORDER AND ASSOCIATED DISABILITIES INTERVIEW SCHEDULE DSM 5 VERSION; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; CORRELATION COEFFICIENT; DEPRESSION; DSM-5; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHIATRIC RESEARCH INTERVIEW FOR SUBSTANCE AND MENTAL DISORDERS DSM 5 VERSION; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; VALIDITY; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DRUG USE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; REPRODUCIBILITY; STANDARDS; STRESS DISORDERS, POST-TRAUMATIC; VALIDATION STUDY;

ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DRUG USERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84930474811     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.03.027     Document Type: Article

References (47)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorder 1994, American Psychiatric Association Publishing, Washington, DC. 4th edition.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorder 2013, American Psychiatric Association Publishing, Washington, DC. 5th edition.
3. Aziz M.A., Kenford S. Comparability of telephone and face-to-face interviews in assessing patients with posttraumatic stress disorder. J. Psychiatry Pract. 2004, 10:307-313.
4. Canino G., Bravo M., Ramirez R., Febo V.E., Rubio-Stipec M., Fernandez R.L., Hasin D. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J. Stud. Alcohol 1999, 60:790-799.
5. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004, 291:2114-2121.
6. Cottler L.B., Grant B.F., Blaine J., Mavreas V., Pull C., Hasin D., Compton W.M., Rubio-Stipec M., Mager D. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997, 47:195-205.
7. Cuenca-Royo A.M., Sanchez-Niubo A., Forero C.G., Torrens M., Suelves J.M., Domingo-Salvany A. Psychometric properties of the CAST and SDS scales in young adult cannabis users. Addict. Behav. 2012, 37:709-715.
8. Davis M., Fleiss J.L. Measuring agreement for multinomial data. Biometrics 1982, 38:1047-1051.
9. Drake R.E., Caton C.L., Xie H., Hsu E., Gorroochurn P., Samet S., Hasin D.S. A prospective 2-year study of emergency department patients with early-phase primary psychosis or substance-induced psychosis. Am. J. Psychiatry 2011, 168:742-748.
10. Faraone S.V. Real progress in molecular psychiatric genetics. J. Am. Acad. Child Adol. Psychiatry 2013, 52:1006-1008.
11. Fazzino T.L., Rose G.L., Burt K.B., Helzer J.E. Comparison of categorical alcohol dependence versus a dimensional measure for predicting weekly alcohol use in heavy drinkers. Drug Alcohol Depend. 2014, 136:121-126.
12. Fleiss J.L. The Measurement Of Interrater Agreement, Formula 13. 22. Statistical Methods For Rates And Proportions 1981, 222. John Wiley and Sons, Inc, New York.
13. Fleiss J.L. Statistical Methods For Rates And Proportions 1981, John Wiley and Sons, Inc, New York.
14. Grant B.F. Source And Accuracy Statement: National Epidemiologic Survey On Alcohol And Related Conditions-III (NESARC-III). 2014, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, http://www.niaaa.nih.gov/research/nesarc-iii.
15. Grant B.F., Dawson D.A., Hasin D.S. The Alcohol Use Disorder and Associated Disabilities Interview Schedule Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition Version (AUDADIS-IV) 2001, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
16. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71:7-16.
17. Grant B.F., Dawson D.A., Stinson F.S., Chou S.P., Dufour M.C., Pickering R.P. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 2004, 74:223-234.
18. Grant B.F., Goldstein R., Aivadyan C., Hasin D. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Version (AUDADIS-5) 2011, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
19. Grant B.F., Goldstein R., Smith S.M., Jung J., Zhang H., Chou S.P., Pickering R.P., Ruan W.J., Huang B., Saha T., Aivadyan C., Greenstein E., Hasin D.S. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend. 2015, 148:27-33.
20. Grant B.F., Goldstein R.B., Chou S.P., Huang B., Stinson F.S., Dawson D.A., Saha T.D., Smith S.M., Pulay A.J., Pickering R.P., Ruan W.J., Compton W.M. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry 2009, 14:1051-1066.
21. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
22. Haro J.M., Arbabzadeh-Bouchez S., Brugha T.S., de Girolamo G., Guyer M.E., Jin R., Lepine J.P., Mazzi F., Reneses B., Vilagut G., Sampson N.A., Kessler R.C. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int. J. Methods. Psychiatry Res. 2006, 15:167-180.
23. Hasin D., Liu X., Nunes E., McCloud S., Samet S., Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch. Gen. Psychiatry 2002, 59:375-380.
24. Hasin D., Samet S., Nunes E., Meydan J., Matseoane K., Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am. J. Psychiatry 2006, 163:689-696.
25. Hasin, D.S., in press. The NESARC, Waves 1 and 2: a decade of research findings. Addiction.
26. Hasin D.S., Aivadyan C., Greenstein E., Grant B.F. Psychiatric Research Interview for Substance Use and Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PRISM-5) version 2011, Columbia University, Department of Psychiatry, New York, NY.
27. Hasin D.S., Fenton M.C., Beseler C., Park J.Y., Wall M.M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend. 2012, 122:28-37.
28. Hasin D.S., Greenstein E., Aivadyan C., Stohl M., Aharonovich E., Saha T., Goldstein R., Nunes E.V., Jung J., Zhang H., Grant B.F. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend. 2015, 148:40-46.
29. Hasin D.S., O'Brien C.P., Auriacombe M., Borges G., Bucholz K., Budney A., Compton W.M., Crowley T., Ling W., Petry N.M., Schuckit M., Grant B.F. DSM-5 criteria for substance use disorders: recommendations and rationale. Am. J. Psychiatry 2013, 170:834-851.
30. Hasin D.S., Trautman K.D., Miele G.M., Samet S., Smith M., Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am. J. Psychiatry 1996, 153:1195-1201.
31. Helzer J.E., Robins L.N., McEvoy L.T., Spitznagel E.L., Stoltzman R.K., Farmer A., Brockington I.F. A comparison of clinical and diagnostic interview schedule diagnoses. Physician reexamination of lay-interviewed cases in the general population. Arch. Gen. Psychiatry 1985, 42:657-666.
32. Kessler R.C., Avenevoli S., Green J., Gruber M.J., Guyer M., He Y., Jin R., Kaufman J., Sampson N.A., Zaslavsky A.M. National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments. J. Am. Acad. Child. Adol. Psychiatry 2009, 48:386-399.
33. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
34. McInnes D.K., Li A.E., Hogan T.P. Opportunities for engaging low-income, vulnerable populations in health care: a systematic review of homeless persons' access to and use of information technologies. Am. J. Public Health 2013, 103(Suppl. 2):e11-e24.
35. Mestre-Pinto J.I., Domingo-Salvany A., Martin-Santos R., Torrens M., PsyCoBarcelona G. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument. Eur. Addict. Res. 2014, 20:41-48.
36. Nunes E.V., Liu X., Samet S., Matseoane K., Hasin D. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up. J. Clin. Psychiatry 2006, 67:1561-1567.
37. Regier D.A., Kuhl E.A., Narrow W.E., Kupfer D.J. Research planning for the future of psychiatric diagnosis. Eur. Psychiatry 2012, 27:553-556.
38. Shoukri M.M. December 2010. p.50. Measures Of Inter-Observer Agreement and Reliability 2010, Chapman & Hall/CRC Press, Boca Raton, Florida. 2nd Edition.
39. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol. Bull 1979, 86:420-428.
40. Sobin C., Weissman M.M., Goldstein R.B., Adams P., Wickramaratne P., Warner V., Lish J.D. Diagnostic interviewing for family studies: comparing telephone vs. face-to-face methods for the diagnosis of lifetime psychiatric disorders. Psychiatry Genet. 1993, 3:227-233.
41. Torrens M., Gilchrist G., Domingo-Salvany A. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend. 2011, 113:147-156.
42. Torrens M., Serrano D., Astals M., Perez-Dominguez G., Martin-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am. J. Psychiatry 2004, 161:1231-1237.
43. United States Census Bureau, 2011. Extended Measures of Well-being: Living Conditions in the United States, 2011. accessed on August 5, 2014. http://www.census.gov/hhes/well-being/publications/extended-11.html.
44. Wells K.B., Burnam M.A., Leake B., Robins L.N. Agreement between face-to-face and telephone-administered versions of the depression section of the NIMH Diagnostic Interview Schedule. J. Psychiatry Res. 1988, 22:207-220.
45. Westat, https://www.westat.com/ accessed 20.01.15.
46. Wittchen H.U., Kessler R.C., Zhao S., Abelson J. Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. J. Psychiatry Res. 1995, 29:95-110.
47. Wittchen H.U., Zhao S., Abelson J.M., Abelson J.L., Kessler R.C. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol. Med. 1996, 26:1169-1177.